Post-market surveillance systems, such as the Vaccine Adverse Event Reporting System (VAERS), continue to monitor the safety and efficacy of interventions after they are approved. These systems collect data on adverse events from healthcare providers and the public, helping to identify any long-term or rare side effects.
